Article Text

other Versions

PDF
HER2 testing in the UK - further update to recommendations
  1. Rosemary A Walker (raw14{at}le.ac.uk)
  1. University of Leicester, United Kingdom
    1. John Bartlett (jbartlet{at}ed.ac.uk)
    1. University of Edinburgh, United Kingdom
      1. Mitch Dowsett (mitch.dowsett{at}icr.ac.uk)
      1. Royal Marsden Hospital, United Kingdom
        1. Ian O Ellis (ian.ellis{at}nottingham.ac.uk)
        1. University of Nottingham, United Kingdom
          1. Andrew Hanby (a.m.hanby{at}leeds.ac.uk)
          1. University of Leeds, United Kingdom
            1. Bharat Jasani (jasani{at}cardiff.ac.uk)
            1. University of Cardiff, United Kingdom
              1. Keith Miller (rmkdhkm{at}ucl.ac.uk)
              1. UCL, United Kingdom
                1. Sarah Pinder (sarah.pinder{at}kcl.ac.uk)
                1. Kings College London, United Kingdom

                  Abstract

                  These guidelines update the previous UK HER2 testing guidelines and have been formulated to give advice on methodology, interpretation and quality assurance to ensure that HER2 testing results are accurate, reliable and timely with the expansion of testing to all breast cancer patients at the time of primary diagnosis. The recommendations for testing are the use of immunohistochemistry but with analysis of equivocal cases by in situ hybridisation to clarify their HER2 status or the use of frontline fluorescence in situ hybridisation (FISH) testing for those laboratories wishing to do so; the inclusion of a chromosome 17 probe is strongly recommended. Laboratories using chromogenic or silver in situ hybridisation should perform an initial validation against FISH. For immunohistochemistry and in situ hybridisation there must be participation in the appropriate National External Quality Assurance scheme.

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.